FDA Drug Application (018279) for K-TAB by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number018279
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage10MEQ
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code BC Extended-release dosage forms (capsules, injectables and tablets)
Reference Drug
Drug NameK-TAB
Active IngredientPOTASSIUM CHLORIDE



Back to FDA Applications sponsored by ABBVIE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.